256 related articles for article (PubMed ID: 5058704)
1. Effects of amantadine hydrochloride on catecholamine metabolism in the brain of the rat.
Baldessarini RJ; Lipinski JF; Chace KV
Biochem Pharmacol; 1972 Jan; 21(1):77-87. PubMed ID: 5058704
[No Abstract] [Full Text] [Related]
2. Dopamine and norepinephrine uptake by rat brain synaptosomes: relative inhibitory potencies of 1- and d-amphetamine and amantadine.
Thornburg JE; Moore KE
Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):81-9. PubMed ID: 4686111
[No Abstract] [Full Text] [Related]
3. Amantadine and catecholamine uptake.
Herblin WF
Biochem Pharmacol; 1972 Jul; 21(14):1993-5. PubMed ID: 4649347
[No Abstract] [Full Text] [Related]
4. 3H-normetanephrine uptake in rat brain slices. Relationship to extraneuronal accumulation of norepinephrine.
Hendley ED; Taylor KM; Snyder SH
Eur J Pharmacol; 1970 Oct; 12(2):167-79. PubMed ID: 4394372
[No Abstract] [Full Text] [Related]
5. Effects of 5,6-dihydroxytryptamine on monoaminergic neurones in the central nervous system of the rat.
Baumgarten HG; Evetts KD; Holman RB; Iversen LL; Vogt M; Wilson G
J Neurochem; 1972 Jun; 19(6):1587-97. PubMed ID: 4402486
[No Abstract] [Full Text] [Related]
6. The effect of amantadine on radiolabeled biogenic amines in the rat brain.
Symchowicz S; Korduba CA; Veals J
Eur J Pharmacol; 1973 Feb; 21(2):155-60. PubMed ID: 4696098
[No Abstract] [Full Text] [Related]
7. Putative neurotransmitters in the brain: selective neuronal uptake, subcellular localization, and interactions with centrally acting drugs.
Snyder SH
Biol Psychiatry; 1970 Oct; 2(4):367-89. PubMed ID: 4320227
[No Abstract] [Full Text] [Related]
8. Uptake and release of norepinephrine by rat brain tissue fractions prepared by ultrafiltration.
Baldessarini RJ; Vogt M
J Neurochem; 1971 Jun; 18(6):951-62. PubMed ID: 5567914
[No Abstract] [Full Text] [Related]
9. Rapid effects of monoamine oxidase inhibitors on synthesis and release of central monoamines.
Glowinski J; Hamon M; Javoy F; Morot-Gaudry Y
Adv Biochem Psychopharmacol; 1972; 5():423-39. PubMed ID: 4403372
[No Abstract] [Full Text] [Related]
10. Catecholamine metabolism in hypertensive rats.
Louis WJ; Krauss KR; Kopin IJ; Sjoerdsma A
Circ Res; 1970 Oct; 27(4):589-94. PubMed ID: 5472848
[No Abstract] [Full Text] [Related]
11. Catecholamine uptake by synaptosomes from rat brain. Structure-activity relationships of drugs with differential effects on dopamine and norepinephrine neurons.
Horn AS; Coyle JT; Snyder SH
Mol Pharmacol; 1971 Jan; 7(1):66-80. PubMed ID: 5552252
[No Abstract] [Full Text] [Related]
12. Influence of debrisoquin (Declinax) on adrenergic function and norepinephrine metabolism.
Horst WD; Gattanell P
Biochem Pharmacol; 1970 Jul; 19(7):2335-41. PubMed ID: 5520376
[No Abstract] [Full Text] [Related]
13. Errors introduced by a tritium label in position 8 of catecholamines.
Grohmann M; Henseling M; Cassis L; Trendelenburg U
Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan; 332(1):34-42. PubMed ID: 2419773
[TBL] [Abstract][Full Text] [Related]
14. The effect of amantadine on the uptake of dopamine and noradrenaline by rat brain homogenates.
Fletcher EA; Redfern PH
J Pharm Pharmacol; 1970 Dec; 22(12):957-9. PubMed ID: 4395527
[No Abstract] [Full Text] [Related]
15. [The action of 1-aminoadamantane. Comparative studies with isolated nerve endings and thrombocytes on the release of serotonin and dopamine].
Haacke U; Sturm G; Süwer V; Wesemann W; Wildenhahn G
Arzneimittelforschung; 1977 Jul; 27(7):1481-3. PubMed ID: 578478
[TBL] [Abstract][Full Text] [Related]
16. The physiologic disposition and metabolism of norepinephrine in immunosympathectomized animals.
Iversen LL; Glowinski J; Axelrod J
J Pharmacol Exp Ther; 1966 Feb; 151(2):273-84. PubMed ID: 5932603
[No Abstract] [Full Text] [Related]
17. Proceedings: The effect of amantadine on the turnover of catecholamines in the rat brain.
Brown F; Redfern PH
J Pharm Pharmacol; 1974 Dec; 26 Suppl():81P-82P. PubMed ID: 4156763
[No Abstract] [Full Text] [Related]
18. Selectivity of release of norepinephrine, dopamine and 5-hydroxytryptamine by amphetamine in various regions of rat brain.
Azzaro AJ; Rutledge CO
Biochem Pharmacol; 1973 Nov; 22(22):2801-13. PubMed ID: 4761552
[No Abstract] [Full Text] [Related]
19. Evaluation of amantadine as a releasing agent or uptake blocker for H 3 -dopamine in rat brain slices.
Heikkila RE; Cohen G
Eur J Pharmacol; 1972 Nov; 20(2):156-60. PubMed ID: 4651205
[No Abstract] [Full Text] [Related]
20. Some puzzling pharmacological effects of monoamine oxidase inhibitors.
Knoll J; Magyar K
Adv Biochem Psychopharmacol; 1972; 5():393-408. PubMed ID: 5066229
[No Abstract] [Full Text] [Related]
[Next] [New Search]
